Ebola vaccine gold rush: Tekmira investors need a full-blown pandemic to really cash in

“(NaturalNews) How do you make money from a deadly pandemic? According to tens of thousands of investors, you plow money into Tekmira Pharmaceuticals, the company that’s suddenly the darling of the pharmaceutical industry due to its early R&D work on an Ebola vaccine.”
Read the whole article here!



Go back to: Healthy Being – Discovering a healthy common sense

Comments are closed.